Avadel Pharmaceuticals (AVDL) Gross Profit: 2009-2020
Historic Gross Profit for Avadel Pharmaceuticals (AVDL) over the last 10 years, with Jun 2020 value amounting to $6.8 million.
- Avadel Pharmaceuticals' Gross Profit fell 51.15% to $6.8 million in Q2 2020 from the same period last year, while for Jun 2020 it was $36.6 million, marking a year-over-year decrease of 39.48%. This contributed to the annual value of $16.6 million for FY2020, which is 64.77% down from last year.
- Avadel Pharmaceuticals' Gross Profit amounted to $6.8 million in Q2 2020, which was down 30.45% from $9.8 million recorded in Q1 2020.
- In the past 5 years, Avadel Pharmaceuticals' Gross Profit registered a high of $48.6 million during Q1 2017, and its lowest value of $6.8 million during Q2 2020.
- In the last 3 years, Avadel Pharmaceuticals' Gross Profit had a median value of $13.6 million in 2019 and averaged $14.9 million.
- Its Gross Profit has fluctuated over the past 5 years, first spiked by 1,041.98% in 2016, then plummeted by 53.45% in 2018.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Gross Profit stood at $40.5 million in 2016, then fell by 24.18% to $30.7 million in 2017, then plummeted by 45.84% to $16.6 million in 2018, then plummeted by 48.39% to $8.6 million in 2019, then plummeted by 51.15% to $6.8 million in 2020.
- Its last three reported values are $6.8 million in Q2 2020, $9.8 million for Q1 2020, and $8.6 million during Q4 2019.